☆ 4.7 Article

Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer

CLINICA CHIMICA ACTA (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Medical Laboratory Technology

rRT-PCR for SARS-CoV-2: Analytical considerations

Rezgar Rahbari et al.

Summary: The COVID-19 pandemic is a significant global health problem that requires accurate and early detection for control and treatment; real-time reverse-transcriptase polymerase-chain-reaction (rRT-PCR) is the gold standard, but false negative results and errors are possible; sources of error include pre-analytical, analytical, and post-analytical phases.

CLINICA CHIMICA ACTA (2021)

添加到收藏夹

Article Infectious Diseases

Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study

Arnaud G. L'Huillier et al.

Summary: This study evaluated the persistence of antibodies against SARS-CoV-2 in hospital employees with mild COVID-19, finding that neutralizing antibodies were detectable in almost all participants at 6 months post infection. Anti-RBD antibodies showed better persistence and even increased over time, possibly due to the detection of progressively higher-affinity antibodies.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Microbiology

Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation

Victoria Higgins et al.

Summary: A study evaluating the quantitative Roche Elecsys anti-SARS-CoV-2 S assay showed high sensitivity, specificity, and positive predictive value in detecting SARS-CoV-2 antibodies post-infection. The study also demonstrated the assay's highest sensitivity at 15 to 30 days post-KR positivity and varying negative predictive values at different time points post-PCR positivity.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

添加到收藏夹

Review Immunology

SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response

Adi Gundlapalli et al.

Summary: There is a current lack of standardized SARS-CoV-2 quantitative IgG and neutralization assays, which hinders the comparison of results from different studies. Most studies have used in-house laboratory-developed tests with non-standardized reporting methods. It is vital to enhance interassay and interlaboratory validation and standardization in order to better understand immune responses and vaccine efficacy.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Biochemical Research Methods

Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review

Jyoti Choudhary et al.

Summary: The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 originated from China has affected the global economy and human resources. Research on medical treatments including herbal remedies, antiviral drugs, and vaccines is ongoing. SARS-CoV-2 is more virulent than its ancestors due to mutations in the spike protein(s) facilitating viral attachment to host cells.

BIOLOGICAL PROCEDURES ONLINE (2021)

添加到收藏夹

Review Cell Biology

SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population

Thomas Vogl et al.

Summary: This review discusses different types of antibody tests against SARS-CoV-2 and their application for population-scale testing, as well as biases due to varying test accuracy and results of large-scale serological studies. Although current efforts in SARS-CoV-2 antibody testing have provided valuable insights, the accuracy of serological tests and the criteria for selecting tested cohorts need to be carefully evaluated.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Review Public, Environmental & Occupational Health

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives

Balasubramanian Ganesh et al.

Summary: SARS-CoV-2 is the causative agent of COVID-19, which originated in Wuhan, China, causing a global public health crisis. This review compares it with SARS and MERS, providing insights for future prevention, control, and treatment strategies.

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)

添加到收藏夹

Article Medical Laboratory Technology

Comparison of the Elecsys (R) Anti-SARS-CoV-2 immunoassay with the EDI (TM) enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma

Margot Egger et al.

CLINICA CHIMICA ACTA (2020)

添加到收藏夹

Letter Medical Laboratory Technology

Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies

Julien Favresse et al.

CLINICAL CHEMISTRY (2020)

添加到收藏夹

Letter Medical Laboratory Technology

Clinical Performance of the Roche SARS-CoV-2 Serologic Assay

Mei San Tang et al.

CLINICAL CHEMISTRY (2020)

添加到收藏夹

Article Medical Laboratory Technology

IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2

Mary Kathryn Bohn et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

添加到收藏夹

Article Medical Laboratory Technology

IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection

Mary Kathryn Bohn et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

添加到收藏夹

Review Medical Laboratory Technology

Update on serologic testing in COVID-19

Rafal Krajewski et al.

CLINICA CHIMICA ACTA (2020)

添加到收藏夹

Article Medical Laboratory Technology

Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19

Raymond T. Suhandynata et al.

JOURNAL OF APPLIED LABORATORY MEDICINE (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.